Find and Pitch Jounalists, Get Your Story Covered

Tags: Monoclonal Antibodies Cancer Antibody Research Bispecific Antibodies DLBCL Trials

	Profile	Recent Articles on Subject
1	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - 8 days ago
2	Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Resources and Education for Operationalizing Bispecifics - 12 days ago Dosing Frequency and Formulary Decisions for Bispecific Antibodies - 19 days ago Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - 26 days ago Current Landscape of Bispecific Therapies for RRMM - 26 days ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	FDA Approves Zanidatamab for Biliary Tract Cancer - 30 days ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 3 months ago Novel Monoclonal Antibody Reduces Bleeds in Hemophilia A and B - about 1 year ago Year in Review: Follicular Lymphoma - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 30 days ago
5	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’ - about 2 months ago Merck Picks Up Novel Bispecific Antibody With Potential in Both Cancer & Autoimmune Disease - 4 months ago Ipsen Turns to China-Based Biotech to Get Another ADC Cancer Drug - 5 months ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - about 2 months ago Addressing Challenges When Implementing Bispecific Antibodies in Diverse Settings - 6 months ago Addressing the Challenges of Implementing Bispecific Antibodies in Health Care Centers - 9 months ago Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma - 9 months ago
7	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Oncimmune announces new contract with global pharma company - 4 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 6 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 9 months ago FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications - 10 months ago FDA Approves 2 Denosumab Biosimilars for All Indications of Reference Products - 10 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 10 months ago Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months - 11 months ago Biosimilar SB8 Is Comparable to Bevacizumab for Non–Small Cell Lung Cancer - 11 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 12 months ago
9	Elizabeth Short MedPage Today Editorial intern @medpagetoday. New York, New York Journalismediting	Novel Antibody for Chronic Hives Brings Relief in Mid-Stage Trial - 10 months ago
10	Ryan Haumschild Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody - 11 months ago

Journalists covering Bispecific Antibodies